Comparison of IPX054 and Immediate-Release Carbidopa-Levodopa in Patients With Parkinson's Disease

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions

Parkinson's Disease

Interventions

DRUG

IPX054 200 mg

IPX054 containing 50 mg carbidopa and 200 mg levodopa

DRUG

CD-LD IR

CD-LD IR containing 25 mg carbidopa and 100 mg levodopa

DRUG

IPX054 Placebo

Placebo to match IPX054 200 mg

DRUG

CD-LD IR Placebo

Placebo to match CD-LD IR

Trial Locations (2)

Site 2, Charleston

Site 1, Chicago